LIPIODOL ULTRA FLUIDE

国家: 印度尼西亚

语言: 印度尼西亚文

来源: Badan Pengawas Obat dan Makanan RI - Indonesian Food and Drug Supervisory Agency

下载 产品特点 (SPC)
19-10-2022

有效成分:

ETHER, SOLVENT

可用日期:

NICHOLAS LAB INDONESIA - Indonesia

INN(国际名称):

ETHER, SOLVENT

剂量:

48%

药物剂型:

CAIRAN INJEKSI

每包单位数:

DUS, 50 AMPUL @ 10 ML

厂商:

UERBET AULNAY SOUS BOIS - France

授权日期:

2019-01-21

产品特点

                                SUMMARY OF PRODUCT CHARACTERISTICS
NAME OF THE MEDICINAL PRODUCT
LIPIODOL ULTRA-FLUIDE (480 mg I/ml), solution for injection.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Ethyl esters of iodized fatty acids of poppy seed oil * qs ad for one
ampoule
* Iodine content: 48 %, i.e. 480 mg per ml.
PHARMACEUTICAL FORM
Solution for injection.
CLINICAL PARTICULARS
THERAPEUTIC INDICATIONS
In diagnostic radiology
-
Lymphography
-
Hysterosalpingography (HSG) in women undergoing infertility workup
In interventional radiology
- Visualisation, localisation and vectorisation during Trans-Arterial
Chemo-Embolisation
(TACE) of hepatocellular carcinoma at intermediate stage, in adults.
POSOLOGY AND METHOD OF ADMINISTRATION
LIPIODOL ULTRA-FLUIDE must be administered by slow injection or by
catheter using an
appropriate a glass syringeand a catheter.
In diagnostic radiology
-
Lymphography
The usual dose is 5 to 7 ml via the strict lymphatic route to enhance
contrast in an extremity
(depending on the height of the patient), i.e. 10 to 14 ml for
bilateral lymphography of the
feet.
-
Hysterosalpingography
Inject increments of 2 mL of LIPIODOL ULTRA FLUIDE into the
endometrial cavity under
fluoroscopic control until tubal patency is determined.
The total volume to be injected depends on the volume of the uterine
cavity, usually not
exceeding 15 mL.
The dose of LIPIODOL ULTRA FLUIDE for hysterosalpingography should be
kept as low as
possible to minimize the potential risk of thyroid dysfunction.
DISETUJUI OLEH BPOM: 10 OKTOBER 2022
ID EREG10028812100002
Administration in hysterosalpingography is by slow injection into the
uterine cervical canal
via a suitable catheter or cannula. Stop the injection if the patient
develops excessive
discomfort. The examination should be preferably carried out during
the follicular phase of
the menstrual cycle.
In interventional radiology:
• Trans-Arterial Chemo-Embolisation of hepatocellular carcinoma:
The administration is by selective intra-arterial catheterism of the
hepatic artery. The
procedure should b
                                
                                阅读完整的文件
                                
                            

搜索与此产品相关的警报